Discovery to Impact: The Medicine by Design Project Showcase in pictures
Full day event celebrates eight years of success and explores future directions
Twenty-nine Therapeutics and Re:Pair Genomics win first and second place at Medicine by Design’s Building a Biotech Venture Pitch Competition
Pitches focused on treating a difficult form of cancer and enhancing gene therapy treatments take the top spots
Six teams will compete for funding at the fourth annual Building a Biotech Venture Pitch Competition on March 27
$25K and $10K will be awarded to the top regenerative or precision medicine innovations
Working Towards Inclusivity Symposium brings Toronto research trainees together to examine benefits of diversity in labs
Event hosted by Medicine by Design’s Healthy and Inclusive Labs committee and Working Towards Inclusivity in Chemistry Toronto
Five ways Medicine by Design is transforming the treatment of liver disease
Medicine by Design-funded researchers are leading the way in ground-breaking liver research
Using stem cells for liver regeneration
Stem cell pioneer Gordon Keller, director of the University Health Network's McEwen Stem Cell Institute, leads a team of eight labs focused on harnessing the liver’s power to regenerate. Read more.
Mapping the liver
The University of Toronto's Gary Bader, along with University Health Network researchers Sonya MacParland, and Ian McGilvray, have collaborated on a world first: generating a “map” of all cells of the human liver. Read more.
Making a bile duct
The University of Toronto's Axel Guenther’s lab has developed collagen tubes that hold potential to be developed into lab-grown bile ducts, with the aim of being able to replace this part of the organ in a patient. Read more.
Studying cystic fibrosis-linked liver disease
Christine Bear's lab at The Hospital for Sick Children (SickKids), along with other labs, is working on treating cystic fibrosis-linked liver disease with regenerative medicine approaches. Read more.
Moving liver cell therapy toward the clinic
Shinichiro Ogawa, a scientist at the McEwen Stem Cell Institute, University Health Network, is focused on the early-stage translation of the liver cells from experiment to clinical application. Read more.
Op-ed: Canada’s biomedical brain drain is reversing. Let’s continue that trend
For Canadians to benefit from biomedical innovations, we must build a thriving ecosystem
Pioneering patient-guided study helps map rare liver disease
Innovative study unveils rare liver disease secrets
Medicine by Design symposium panel and announcement put a focus on intentional innovation through partnerships
The symposium — themed “Intentional Innovation” — attracted more than 750 registrants
Medicine by Design and CCRM announce strategic alliance to bolster Canada’s globally-leading position in regenerative medicine
This alliance is set to unlock Toronto's potential as a globally-leading ecosystem for regenerative medicine
Scientists create “cloaked” donor cell and tissue grafts that escape rejection by the immune system
New research could transform cell therapies for incurable diseases